BCR-ABL driven K562 was the only cell line to be clearly resistant, but BCR-ABL T-ALL cell lines BV-173 and TOM-1 were highly sensitive to OTX015 treatment, which hints to other resistance mechanisms in K562 cells. This evidence concerns the gene ABL1 and acute lymphoblastic leukemia.